Related Experiment Video
Updated: Aug 15, 2026
08:31
Bioprinting of Hydrogel Tumor Slices as a 3D Model for Mantle Cell Lymphoma
Published on: September 12, 2025
Follicular lymphoma: a therapeutic update
Antoine Italiano1, Antoine Thyss
1Centre régional de lutte contre le cancer Antoine-Lacassagne, département d'hématologie, 33, avenue de Valombrose, 06189 Nice cedex 2, France. antoineitaliano@cario.fr
Bulletin Du Cancer
|November 4, 2005
Summary
Follicular lymphoma, a common indolent non-Hodgkin
Area of Science:
- Hematology
- Oncology
- Clinical Therapeutics
Background:
- Follicular lymphoma is the most prevalent low-grade non-Hodgkin's lymphoma, characterized by an indolent progression and frequent relapses.
- The disease typically presents with advanced stage at diagnosis, limiting curative potential of radiotherapy for most patients.
- Median survival is approximately 10 years, highlighting the need for effective long-term management strategies.
Purpose of the Study:
- To review current and emerging treatment options for follicular lymphoma.
- To emphasize recent advancements in therapeutic strategies based on phase III clinical trials.
- To provide an overview of treatments for patients with advanced follicular lymphoma.
Main Methods:
- Comprehensive review of published literature on follicular lymphoma treatments.
- Focus on phase III clinical trials evaluating efficacy and safety of various therapeutic modalities.
- Analysis of emerging therapies including antibody therapy, chemotherapy combinations, radioimmunotherapy, and stem cell transplantation.
Main Results:
- Radiotherapy offers curative potential only in a small subset of patients with localized disease.
- A significant increase in the use of novel therapies like antibody-based treatments and stem cell transplantation in the last five years.
- Current therapies for advanced follicular lymphoma lack definitive curative evidence, necessitating ongoing treatment.
Conclusions:
- Follicular lymphoma management requires a shift towards novel therapeutic approaches due to its indolent and relapsing nature.
- Emerging therapies show promise in improving outcomes for patients with advanced disease.
- Continued evaluation through phase III trials is crucial for establishing the role of new treatments in follicular lymphoma.
Related Concept Videos
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
01:15Secondary Lymphoid Organs
Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...
01:16Primary Lymphoid Organs
Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...
01:18Lymphoid Cells and Tissues
Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...